Melinta seeks buyout bids to secure escape from bankruptcy

Melinta seeks buyout bids to secure escape from bankruptcy

Source: 
Fierce Biotech
snippet: 

A U.S. bankruptcy court has given groups interested in buying antibiotic biotech Melinta Therapeutics until March 2 to make an offer. The bidding process creates an opportunity for Melinta’s business to continue as a going concern despite its financial difficulties.